Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple Sclerosis
Author(s) -
Nathaniel Lizak,
Charles B. Malpas,
Sifat Sharmin,
Eva Havrdová,
Dana Horáková,
Guillermo Izquierdo,
Sara Eichau,
Alessandra Lugaresi,
Pierre Duquette,
Marc Girard,
Alexandre Prat,
Catherine Larochelle,
María Trojano,
François Grand’Maison,
Pierre Grammond,
Patrizia Sola,
Diana Ferraro,
Raymond Hupperts,
Roberto Bergamaschi,
Cavit Boz,
Vincent Van Pesch,
Daniele Spitaleri,
Murat Terzi,
Tomáš Kalinčík,
MSBase Study Group
Publication year - 2020
Publication title -
jama neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.298
H-Index - 231
eISSN - 2168-6157
pISSN - 2168-6149
DOI - 10.1001/jamaneurol.2020.2453
Subject(s) - multiple sclerosis , medicine , association (psychology) , immunotherapy , active immunotherapy , oncology , physical therapy , psychology , immunology , psychotherapist , cancer
It is unclear whether relapses and disease-modifying therapies are associated with the rate of disability accumulation in patients with secondary progressive multiple sclerosis (SPMS).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom